Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Unity Biotechnology, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +1 vs. Q3 2024
- Shares held
- 3.18M
- −157.3K (−4.7%) vs. Q3 2024
- Total value
- $3.10M
- −$1.80M (−36.7%) vs. Q3 2024
- New holders
- 6
- 8 more added
- Sold out
- 5
- 7 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $1.68K |
| Q2 2025 | 35 | $987.3K |
| Q1 2025 | 40 | $2.95M |
| Q4 2024 | 37 | $3.10M |
| Q3 2024 | 38 | $5.09M |
| Q2 2024 | 39 | $4.66M |
| Q1 2024 | 40 | $5.87M |
| Q4 2023 | 42 | $8.33M |
| Q3 2023 | 36 | $6.42M |
| Q2 2023 | 40 | $6.87M |
| Q1 2023 | 46 | $5.13M |
| Q4 2022 | 54 | $12.6M |
| Q3 2022 | 72 | $24.1M |
| Q2 2022 | 66 | $5.31M |
| Q1 2022 | 71 | $14.2M |
| Q4 2021 | 72 | $21.3M |
| Q3 2021 | 84 | $42.1M |
| Q2 2021 | 98 | $84.0M |
| Q1 2021 | 92 | $121.8M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Unity Biotechnology, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 120 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3 | $3 | 0.00% | +3 | New |
| Jones Financial Companies LLLP | 26 | $25 | 0.00% | 00.0% | Unchanged |
| HHM Wealth Advisors, LLC | 25 | $25 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 31 | $30 | 0.00% | −30−49.2% | Reduced |
| AllSquare Wealth Management LLC | 55 | $54 | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 100 | $98 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 100 | $98 | 0.00% | +100 | New |
| Bank of America Corp | 127 | $124 | 0.00% | +1+0.8% | Added |
| Signaturefd, LLC | 200 | $195 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 200 | $195 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 266 | $260 | 0.00% | −6−2.2% | Reduced |
| Whittier Trust Co | 360 | $349 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1,000 | $976 | 0.00% | −1,000−50.0% | Reduced |
| Glen Eagle Advisors, LLC | 1,104 | $1.08K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,654 | $2.59K | 0.00% | +595+28.9% | Added |
| SBI Securities Co., Ltd. | 3,362 | $3.28K | 0.00% | +3,362 | New |
| UBS Group AG | 8,235 | $8.04K | 0.00% | +7,848+2,027.9% | Added |
| Endowment Wealth Management, Inc. | 12,475 | $12.2K | 0.01% | −1,020−7.6% | Reduced |
| Advisor Group Holdings, Inc. | 12,628 | $12.4K | 0.00% | +1,165+10.2% | Added |
| Squarepoint Ops LLC | 18,332 | $17.9K | 0.00% | +18,332 | New |
| Susquehanna International Group, LLP | 18,690 | $18.2K | 0.00% | +18,690 | New |
| Jane Street Group, LLC | 21,179 | $20.7K | 0.00% | +21,179 | New |
| Northern Trust Corp | 22,549 | $22.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 24,232 | $24.0K | 0.00% | +120+0.5% | Added |
| State Street Corp | 37,824 | $36.9K | 0.00% | 00.0% | Unchanged |
| Cercano Management LLC | 41,238 | $40.3K | 0.00% | 00.0% | Unchanged |
| Founders Fund V Management, LLC | 49,172 | $48.0K | 2.85% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 50,000 | $48.8K | 0.00% | +25,000+100.0% | Added |
| Renaissance Technologies LLC | 76,911 | $75.1K | 0.00% | −16,759−17.9% | Reduced |
| Morgan Stanley | 80,041 | $78.2K | 0.00% | +35,350+79.1% | Added |
| BlackRock, Inc. | 81,402 | $79.5K | 0.00% | +228+0.3% | Added |
| Geode Capital Management, LLC | 159,407 | $155.7K | 0.00% | −3,835−2.3% | Reduced |
| Vanguard Group Inc | 590,770 | $576.6K | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 859,083 | $838.8K | 0.00% | −60,930−6.6% | Reduced |
| ARCH Venture Management, LLC | 1,004,817 | $981.1K | 0.43% | 00.0% | Unchanged |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −79,354−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −69,210−100.0% | Sold out |
| Ballentine Partners, LLC | 0 | $0 | 0.00% | −57,046−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Mayo Clinic | – | – | – | – | Not filed |
| Carmichael Hill & Associates, Inc. | – | – | – | – | Not filed |